๎๊ฒ์
๎๊ฒ์
๎
PainReform Ltd
PRFX๎ญ๊ด์ฌ ๋ชฉ๋ก์ ์ถ๊ฐ
1.580USD
0.0000.00%
์ข
๊ฐย 05/15, 16:00๏ผET๏ผ์์ธ๋ 15๋ถ ์ง์ฐ๋ฉ๋๋ค
1.35M์๊ฐ์ด์ก
์์คP/E TTM
๎
์์ธํ ๋ด์ฉ์ PainReform Ltd ํ์ฌ
PAINREFORM LTD is a Israel-based pharmaceutical Company. The Companyโs main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.
PainReform Ltd ์ ๋ณด
๎์ข
๋ชฉ ์ฝ๋ PRFX
ํ์ฌ ์ด๋ฆPainReform Ltd
์์ฅ์ผSep 01, 2020
CEOHadar (Ilan)
์ง์ ์2
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃSep 01
์ฃผ์65 Yigal Alon St.
๋์TEL AVIV-YAFO
์ฆ๊ถ ๊ฑฐ๋์NASDAQ OMX - NASDAQ BASIC
๊ตญ๊ฐIsrael
์ฐํธ ๋ฒํธ6744316
์ ํ97237177051
์น์ฌ์ดํธhttps://painreform.com/
์ข
๋ชฉ ์ฝ๋ PRFX
์์ฅ์ผSep 01, 2020
CEOHadar (Ilan)
PainReform Ltd์ ํ์ฌ ์์์ง
๎์ด๋ฆ
์ด๋ฆ/์ง์
์ง์
์ฃผ์ ๋ณด์
๋ณ๋
Mr. Ilan Hadar
Mr. Ilan Hadar
Chief Executive Officer, Chief Financial Officer
Chief Executive Officer, Chief Financial Officer
--
--
Dr. Eli Hazum
Dr. Eli Hazum
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Dr. Sigal Aviel
Dr. Sigal Aviel
Chief Operating Officer
Chief Operating Officer
--
--
Mrs. Rita Keynan
Mrs. Rita Keynan
Vice President - Pharmaceutical Operations
Vice President - Pharmaceutical Operations
--
--
Dr. Ehud Geller, Ph.D.
Dr. Ehud Geller, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Mr. Efi Cohen-Arazi
Mr. Efi Cohen-Arazi
Independent Director
Independent Director
--
--
Dr. Ellen S. Baron
Dr. Ellen S. Baron
Independent Director
Independent Director
--
--
Mr. Augustine J. (Gus) Lawlor
Mr. Augustine J. (Gus) Lawlor
Independent Director
Independent Director
--
--
์ด๋ฆ
์ด๋ฆ/์ง์
์ง์
์ฃผ์ ๋ณด์
๋ณ๋
Mr. Ilan Hadar
Mr. Ilan Hadar
Chief Executive Officer, Chief Financial Officer
Chief Executive Officer, Chief Financial Officer
--
--
Dr. Eli Hazum
Dr. Eli Hazum
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Dr. Sigal Aviel
Dr. Sigal Aviel
Chief Operating Officer
Chief Operating Officer
--
--
Mrs. Rita Keynan
Mrs. Rita Keynan
Vice President - Pharmaceutical Operations
Vice President - Pharmaceutical Operations
--
--
Dr. Ehud Geller, Ph.D.
Dr. Ehud Geller, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Mr. Efi Cohen-Arazi
Mr. Efi Cohen-Arazi
Independent Director
Independent Director
--
--
์์ต ๋ถ์
๊ธฐ์
์ด ์์ง ๊ด๋ จ ๋ฐ์ดํฐ๋ฅผ ๊ณต๊ฐํ์ง ์์์ต๋๋ค.
๊ธฐ์
์ด ์์ง ๊ด๋ จ ๋ฐ์ดํฐ๋ฅผ ๊ณต๊ฐํ์ง ์์์ต๋๋ค.
์ฌ์
๋ณ
์ง์ญ๋ณ
๊ธฐ์
์ด ์์ง ๊ด๋ จ ๋ฐ์ดํฐ๋ฅผ ๊ณต๊ฐํ์ง ์์์ต๋๋ค.
์ฃผ์ ๋ณด์ ํต๊ณ
๋ง์ง๋ง ์
๋ฐ์ดํธ: Thu, Feb 19
๋ง์ง๋ง ์
๋ฐ์ดํธ: Thu, Feb 19
์ฃผ์ฃผ
์ฃผ์ฃผ ์ ํ
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น์จ
Bladeranger Ltd
6.15%
Morgan Stanley & Co. LLC
0.60%
Two Sigma Investments, LP
0.50%
XTX Markets LLC
0.31%
L.I.A. Pure Capital Ltd
0.24%
๊ธฐํ
92.20%
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น์จ
Bladeranger Ltd
6.15%
Morgan Stanley & Co. LLC
0.60%
Two Sigma Investments, LP
0.50%
XTX Markets LLC
0.31%
L.I.A. Pure Capital Ltd
0.24%
๊ธฐํ
92.20%
์ฃผ์ฃผ ์ ํ
์ฃผ์ฃผ
๋น์จ
Corporation
6.39%
Research Firm
0.60%
Hedge Fund
0.50%
Venture Capital
0.31%
Investment Advisor
0.11%
๊ธฐํ
92.09%
๊ธฐ๊ด ์ฃผ์ ๋ณด์
๎๋ง์ง๋ง ์
๋ฐ์ดํธ: Wed, Apr 1
๋ง์ง๋ง ์
๋ฐ์ดํธ: Wed, Apr 1
๋ณด๊ณ ๊ธฐ๊ฐ
๊ธฐ๊ด ์
๋ณด์ ์ฃผ์
๋น์จ
๋ณ๋
2026Q1
16
15.73K
1.84%
-4.77K
2025Q4
15
6.89K
0.88%
-9.63K
2025Q3
15
20.01K
0.99%
-66.86K
2025Q2
22
221.75K
11.02%
-42.46K
2025Q1
21
208.02K
26.50%
+122.57K
2024Q4
19
72.04K
4.22%
+19.22K
2024Q3
16
43.23K
4.31%
+4.77K
2024Q2
16
35.44K
14.31%
+7.32K
2024Q1
15
25.67K
11.49%
-2.27K
2023Q4
17
26.00K
30.19%
+5.33K
๋ ๋ณด๊ธฐ
์ฃผ์ฃผ ํ๋
๎์ด๋ฆ
๋ณด์ ์ฃผ์
๋น์จ
๋ณ๋
Chg %
๋ ์ง
Bladeranger Ltd
35.75K
4.23%
--
--
Apr 01, 2025
Morgan Stanley & Co. LLC
5.12K
0.61%
+5.12K
--
Dec 31, 2025
Two Sigma Investments, LP
4.27K
0.51%
+1.03K
+31.88%
Dec 31, 2025
XTX Markets LLC
2.69K
0.32%
+2.69K
--
Dec 31, 2025
L.I.A. Pure Capital Ltd
2.08K
0.25%
+2.08K
--
Aug 28, 2024
UBS Financial Services, Inc.
868.00
0.1%
+864.00
+21600.00%
Dec 31, 2025
Osaic Holdings, Inc.
39.00
0%
--
--
Dec 31, 2025
Virtu Americas LLC
--
0%
-167.00
-100.00%
Sep 30, 2024
Geode Capital Management, L.L.C.
--
0%
-16.00
-100.00%
Oct 31, 2024
Tower Research Capital LLC
--
0%
-94.00
-100.00%
Jun 30, 2025
๋ ๋ณด๊ธฐ
๊ด๋ จ ETF
๎์ด๋ฆ
๋น์จ
๋ฐ์ดํฐ ์์
์ฃผ์ ๋ฐฐ๋น๊ธ
๎์ง๋ 5๋
๋์ ์ด
0.00
USD์ ๋ฐฐ๋น๊ธ์ด ๋ถ๋ฐฐ๋์์ต๋๋ค.
๋ ์ง
๋ฐฐ๋น๊ธ
๊ธฐ์ค์ผ
์ง๊ธ์ผ
๋ฐฐ๋น๋ฝ์ผ
๋ฐ์ดํฐ ์์
์ฃผ์ ๋ถํ
๎๋ ์ง
๋ฐฐ๋น๋ฝ์ผ
์ ํ
๋น์จ
Feb 03, 2026
Merger
5โ1
Nov 19, 2024
Merger
4โ1
Nov 19, 2024
Merger
4โ1
Nov 19, 2024
Merger
4โ1
Nov 19, 2024
Merger
4โ1
Sep 05, 2024
Merger
6โ1
๋ ์ง
๋ฐฐ๋น๋ฝ์ผ
์ ํ
๋น์จ
Feb 03, 2026
Merger
5โ1
Nov 19, 2024
Merger
4โ1
Nov 19, 2024
Merger
4โ1
Nov 19, 2024
Merger
4โ1
Nov 19, 2024
Merger
4โ1
Sep 05, 2024
Merger
6โ1
Sep 05, 2024
Merger
6โ1
Sep 05, 2024
Merger
6โ1
Sep 05, 2024
Merger
6โ1
Jun 30, 2023
Merger
10โ1
๋ ๋ณด๊ธฐ
